Home
>
National Drug Code (NDC)
>
VANATAB DX
VANATAB DX - 58809-407-01 - (Chlophedianol Hydrochloride, Guaifenesin, Pseudoephedrine Hydrochloride)
Drug Information of VANATAB DX
| Product NDC: | 58809-407 |
| Proprietary Name: | VANATAB DX |
| Non Proprietary Name: | Chlophedianol Hydrochloride, Guaifenesin, Pseudoephedrine Hydrochloride |
| Active Ingredient(s): | 12.5; 200; 30 mg/1; mg/1; mg/1 & nbsp; Chlophedianol Hydrochloride, Guaifenesin, Pseudoephedrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VANATAB DX
| Product NDC: | 58809-407 |
| Labeler Name: | GM Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110906 |
Package Information of VANATAB DX
| Package NDC: | 58809-407-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (58809-407-01) |
NDC Information of VANATAB DX
| NDC Code | 58809-407-01 |
| Proprietary Name | VANATAB DX |
| Package Description | 100 TABLET in 1 BOTTLE (58809-407-01) |
| Product NDC | 58809-407 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Chlophedianol Hydrochloride, Guaifenesin, Pseudoephedrine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110906 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | GM Pharmaceuticals, Inc. |
| Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 12.5; 200; 30 |
| Strength Unit | mg/1; mg/1; mg/1 |
| Pharmaceutical Classes |
